We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Head and neck
Digital Poster
Clinical
Correlation on G8 score with sarcopenia is a prognostic factor for OS in patients with HNC
Kiril Zhelev, Bulgaria
PO-0944
The prognostic value of RDW, NLR, and PLR in radiotherapy for oropharyngeal cancer
Emilia Staniewska, Poland
PO-0945
Treatment outcomes of carcinoma buccal mucosa treated with definitive accelerated radiotherapy
Cessal Thommachan Kainickal, India
PO-0946
Indications for chest computed tomography in the extension study of HNC
Jerónimo Pachón Ibáñez, Spain
PO-0947
Impact of HPV status on normal tissue toxicities experienced by head & neck cancer patients
Xenia Ray, USA
PO-0948
Comparison between simultaneous integrated boost IMRT and sequential IMRT in head and neck cancers
Parveen Ahlawat, India
PO-0949
Comparison between two-dose levels versus three-dose levels IMRT in head and neck cancers
Parveen Ahlawat, India
PO-0950
Effects of COVID-19 during radio(chemo)therapy in head and neck cancer patients
Anna Bandurska-Luque, Poland
PO-0951
A dynamically updating individualized survival prediction modelling tool for oral cancer
Indranil Mallick, India
PO-0952
Impact of human papilloma virus on treatment outcomes in oropharyngeal cancer in India
Nishtha Sachdeva, India
PO-0953
REPORT; REirradiation and PD-1 blockade On Recurrent squamous cell head and neck Tumors
Åse Bratland, Norway
PO-0954
Tumor volume and ADC changes during the time course of RT on a 1.5T MR-Linac in HNC
Simon Boeke, Germany
PO-0955
Radiotherapy in fragile elderly head and neck cancer patients: a single centre experience
Ilaria Luciani, Italy
PO-0956
Organ-preservation in Post-Cricoid and Upper-Esophagus (PCUE) cancers: Seeking optimum outcomes
Shwetabh Sinha, India
PO-0957
Comparison of CCRT and RT alone after Induction Chemotherapy for Hypopharyngeal Cancer
Meng Wan, China
PO-0958
A study correlating type of tobacco use with dosimetry of parotids in H&N patients treated with IMRT
Nikunj Patil, India
PO-0959
Long-term outcome of IMRT-SIB and chemotherapy in nasopharyngeal carcinoma in a non-endemic area
Isabel Linares Galiana, Spain
PO-0960
Role of depth of infiltration (DOI) as independent prognostic factor in pT1--T2 N0 oral tongue SCC
Matteo Augugliaro, Italy
PO-0961
Evaluation of anxiety and depression in head and neck cancer patients during radiotherapy
Muneeb Uddin Karim, Pakistan
PO-0962
How to optimize prognosis prediction of nasopharyngeal carcinoma in the era of modern radiotherapy?
Omar Nouri, Tunisia
PO-0963
Survival outcomes of hypopharyngeal SCC versus cervical oesophageal SCC
Dorothy Gujral, United Kingdom
PO-0964
Vitamin D, vitamin B12 and acute toxicity in head and neck cancer patients undergoing radiotherapy.
Giuseppe Fanetti, Italy
PO-0965
Sarcopenia as prognostic marker in elderly HNSCC patients undergoing (chemo-)radiation
Erik Haehl, Germany
PO-0966
Factors associated with feeding tube requirement in Oropharyngeal Cancer treated with IMRT.
Orla Monaghan, Ireland
PO-0967
ongoing head and neck contour peer review improves quality of radiotherapy targets
Lisa McGee, USA
PO-0968
Evaluation of the use of reirradiation in head and neck recurrent cancer or second primary tumor.
Lucia Gutiérrez Bayard, Spain
PO-0969
Impact nutritional intervention in patients with head and neck cancer receiving radiotherapy.
Lucia Gutiérrez Bayard, Spain
PO-0970
Locally advanced oropharyngeal cancer: a dynamic nomogram
Francesca De Felice, Italy
PO-0971
Pre-treatment haemoglobin as a surrogate marker for survival in head & neck squamous cell carcinoma
Sarthak Tandon, India
PO-0972
Locoregional treatment of primary tumor in synchronous metastatic HNSCC: A retrospective study
Eliane Tang, France
PO-0973
Comparing delineation techniques in radiotherapy of node positive head and neck squamous cell cancer
Chloe Brooks, United Kingdom
PO-0974
ICT Plus Simultaneous Modulated Accelerated Radiation Therapy in Non-operative SCCH/L
Boning Cai, China
PO-0975
Adjuvant (chemo)radiotherapy in HNSCC patients: Outcome prediction with comorbidity risk scores
Sebastian Norbert Marschner, Germany
PO-0976
Comparison of therapy outcomes between 2-dimensional radiotherapy and IMRT for early glottic cancer
Sandeep Purohit, India
PO-0977
Low-dose radiotherapy as a chemosensitizer of neoadjuvant chemotherapy for LA-NPC: a phase II trial
Mei Feng, China
PO-0978
Tumour volume as prognostic factor for recurrent head and neck cancers treated with re-irradiation
Parveen Ahlawat, India
PO-0979
Predicting toxicity after Head-and-Neck cancer RT: synergist role of biological markers & dosimetry?
Ester Orlandi, Italy
PO-0980
Wide histological spectrum of sinonasal malignancies and survival outcomes - An Institutional review
Preetha Umesh, India
PO-0981
early efficacy prediction of NPC based on 3D-ADC during radiotherapy: a phase II prospective study
Mei Feng, China
PO-0982
early prediction of parotid gland function based on ADC during radiotherapy for NPC: a phase Ⅱ study
Mei Feng, China
PO-0983
Impact of anterior commissure involvement in early glottic cancer treated with radical IMRT
Parveen Ahlawat, India
PO-0984
Treatment outcome of 33 versus 35 fractions among nasopharyngeal carcinoma using helical approach
Misael Cruz, Philippines
PO-0985
Radiotherapy versus Surgery in Early Stage HPV-positive Oropharyngeal Cancer
Dong-Yun Kim, Korea Republic of
PO-0986
Evaluation of swallowing function using PSS-HN scale for head-neck cancer patients undergoing IMRT
Prattusha Mukherjee, India
PO-0987
Preliminary evaluation of head and neck malignancies with carbon ion radiotherapy at Osaka HIMAK
Azusa Hasegawa, Japan
PO-0988
Predictive factors for chemoradiotherapy-induced oral mucositis: Human papillomavirus influence
África Fernández Forné, Spain
PO-0989
Treatment package time and Hb in head and neck SCC treated with surgery and post-operative RT
Dorothy Gujral, United Kingdom
PO-0990
Impact of low muscle quality in patients with head and neck cancer undergoing chemoradiation
LILIA BARDOSCIA, Italy
PO-0991
Outcomes and toxicities of curative reirradiation for head and neck carcinomas
Arnaud Beddok, France
PO-0992
Malnutrition by GLIM criteria is a risk factor for survival of NPC patients undergoing radiotherapy
Meng Wan, China
PO-0993
Correlation of PDL1-Tumor Infiltrating Lymphocytes in Carcinoma Oropharynx with toxicity & response
Smriti Srivastava , India
PO-0994
Locally advanced nasopharyngeal carcinoma treated with a mixed beam (photons-protons) radiotherapy.
Irene Turturici, Italy
PO-0995
Dose guided surgery and its impact on the surgical management of mandibular osteoradionecrosis
Nick West, United Kingdom
PO-0996
Lack of CTV_P2 is not associated with a detrimental outcome in oropharyngeal cancer: a cohort study
Lucia Pia Ciccone, Italy
PO-0997
Dosimetric predictors of patient-reported taste alteration in head and neck cancer: a cohort study
Erika Scoccimarro, Italy
PO-0998
Financial difficulties during chemo-radiotherapy for nasopharyngeal carcinoma: A prospective study
Nejla Fourati, Tunisia
PO-0999
Any impact of COVID-19 pandemic on the features of the Head and Neck (HN) cancer patients?
Berardino De Bari, Switzerland
PO-1000
The effect of switching to carboplatin chemo-RT for cycle 2 in cisplatin-ineligible HNSCC patients
James Price, United Kingdom
PO-1001
Variability of pretherapeutic FDG PET/CT parameters in patients with head and neck cancers
François Lucia, France
PO-1002
Implementation of the routine collection of PROMs for patients with Head and Neck cancer
Abigail Bryce-Atkinson, United Kingdom
PO-1003
Prevalence and distribution of cervical lymph node metastases in HPV+ and HPV- oropharyngeal cancer
Laurence Bauwens, France
PO-1004
Intensity-modulated radiotherapy for oropharyngeal carcinoma: oncologic and functional outcomes
AYA Nakajima, Japan
PO-1005
Nutritional intervention in head and neck cancer patients undergoing (chemo-)radiotherapy
Anastassia Löser, Germany
PO-1006
Radiotherapy with delayed accelerated hyperfractionated boost for node negative hypopharynx cancer
Takeshi Fujisawa, Japan
PO-1007
Lymph node ratio dependent utilization of postoperative radiotherapy in T1-2N1 oral cavity carcinoma
Jingbo Wang, China
PO-1008
definitive radiotherapy for squamous cell carcinoma of the external auditory canal
Koyo Kikuchi, Japan
PO-1009
Re-irradiation for head and neck cancer: Cumulative dose and the correlation to carotid blowout
Anna Embring, Sweden
PO-1010
Efficacy of PD-1 inhibition in recurrent Head and Neck cancer. A national prospective cohort study.
Sebastian Søby, Denmark
PO-1011
proposal of new N stage scheme and comparison between seven N schemes in nasopharyngeal carcinoma
Wensa Peng, China
PO-1012
Mastication, swallowing and salivary flow in patients with HNC; objective tests versus PROs
Jorine Vermaire, The Netherlands
PO-1013
Prognosis classifier for elderly head-and-neck squamous cell carcinoma patients
Alexander Rühle, Germany
PO-1014
Prospective evaluation of anatomical changes of salivary glands during MRI-guided ART for HNC
Janita van Timmeren, The Netherlands
PO-1015
External validation of a nomogram for chemoirradiation in stage 2 nasopharyngeal carcinoma with IMRT
Pui Lam Yip, China, Hong Kong Special Administrative Region
PO-1016
Outcome of proton therapy for salivary gland cancer and NTCP risk analysis for xerostomia/dysphagia
Nicolas Bachmann, Switzerland
PO-1017
Dose Escalation in Advanced Floor of the Mouth Cancer Using a Combination of IMRT and SRT Boost
Tomas Blazek, Czech Republic
PO-1018
Influence of glutamine in mucositis secondary to antineoplasic therapies in head and neck cancer.
Ana Torres García , Spain
PO-1019
Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma
Erwin Vu, Switzerland
PO-1020
Postoperative Radiotherapy in the Management of Advanced or Recurrent Differentiated Thyroid Cancer
Hye-Jo Ryu, Korea Republic of
PO-1021
Local-control efficacy of EBRT on well-DTC bone metastases: single center real-life experience
Elisa Lodi Rizzini, Italy
PO-1022
Impact of 18F-FDG-PET/CT in the management of suspected RAI refractory DTC persistence/recurrence
Elisa Lodi Rizzini, Italy
PO-1023
Survival outcomes for p16+ oropharyngeal squamous cell carcinoma based on HPV status
Stephen Robinson, United Kingdom
PO-1024
Outcomes of re-irradiation of relapsed intracranic lesions with stereotactic radiotherapy
Roberta Tummineri, Italy
PO-1025
Re-irradiation with concurrent Nivolumab in locally recurrent Head and Neck Cancer
Jens von der Grün, Switzerland
PO-1026
Radioiodine therapy guided by 124I-PET/CT in metastatic DTC: long-term follow-up data
Elisa Lodi Rizzini, Italy
PO-1027
Inter-correlations between various high-risk pathological factors in squamous cell carcinoma tongue
Parveen Ahlawat, India
PO-1028